Psychedelics and Drug Studies

TopicLeading institutions, researchers & key papers

This cluster of papers explores the therapeutic potential of psychedelic therapy, particularly focusing on the use of substances like psilocybin and MDMA for the treatment of depression, anxiety, and substance dependence. The research delves into the neurobiology, serotonin receptors, and brain function underlying the effects of these psychedelics, as well as their ability to induce mystical experiences and promote long-lasting positive changes in psychological functioning.

100

Works

IDs:OpenAlex

How has Psychedelics and Drug Studies's publication output changed over time?

ScholarIQpublication output · 2010–2022

Output grew0% over the shown period — from 1 works in 2010 to 1 in 2022.

20102012201320152016201820212022

What are the most-cited papers on Psychedelics and Drug Studies?

ScholarIQmost cited works

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

Roland R. Griffiths, Matthew W. Johnson, Michael A. Carducci, Annie Umbricht, William A. Richards, Brian D. Richards, Mary P Cosimano, Margaret A. Klinedinst

Journal of Psychopharmacology. 20162,197 CitationsOPEN ACCESS

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

Robin Carhart‐Harris, David Erritzøe, Tom A. Williams, James Stone, Laurence Reed, Alessandro Colasanti, Robin J. Tyacke, Robert Leech, Andrea L. Malizia, Kevin Murphy, Peter Hobden, John Evans, Amanda Feilding, Richard G. Wise, David Nutt

Proceedings of the National Academy of Sciences. 20121,197 CitationsOPEN ACCESS

Neural correlates of the LSD experience revealed by multimodal neuroimaging

Robin Carhart‐Harris, Suresh Muthukumaraswamy, Leor Roseman, Mendel Kaelen, Wouter Droog, Kevin Murphy, Enzo Tagliazucchi, Eduardo Ekman Schenberg, Timothy Nest, Csaba Orbán, Robert Leech, Luke T. Williams, Tom A. Williams, Mark Bolstridge, Ben Sessa, John McGonigle, Martin I. Sereno, David E. Nichols, Peter J. Hellyer, Peter Hobden, John Evans, Krish D. Singh, Richard G. Wise, H. Valerie Curran, Amanda Feilding, David Nutt

Proceedings of the National Academy of Sciences. 2016889 CitationsOPEN ACCESS

Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial

Fernanda Palhano-Fontes, Dayanna Barreto, Heloisa Onias, Kátia C. Andrade, Morgana Menezes Novaes, Jéssica Andrade Pessoa, Sérgio Mota‐Rolim, Flávia de Lima Osório, Rafael Faria Sanches, Rafael G. dos Santos, Luís Fernando Tófoli, Gabriela de Oliveira Silveira, Maurı́cio Yonamine, Jordi Riba, Francisco R. Santos, Antonio A Silva-Junior, João Carlos Alchieri, Nicole Leite Galvão‐Coelho, Bruno Lobão‐Soares, Jaime E. C. Hallak, Emerson Arcoverde, João Paulo Maia‐de‐Oliveira, Dráulio Barros de Araújo

Psychological Medicine. 2018830 CitationsOPEN ACCESS

Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials

Teri Suzanne Krebs, Pål-Ørjan Johansen

Journal of Psychopharmacology. 2012583 Citations